RECENT NEWS

The UK Health Security Agency (UKHSA) has recently provided specialist laboratory testing for a fridge-free tetanus and diphtheria vaccine that could help address the global challenges of distribution, storage, wastage, and CO2 emissions associated with temperature-sensitive medicines.

Scientists at The Institute of Cancer Research, London, are supporting an international clinical trial of a promising new immunotherapy treatment for advanced ovarian cancer.

Health technology firm Royal Philips has expanded its digital pathology portfolio with new cloud-enabled capabilities designed to help healthcare organisations scale digital diagnostics, improve productivity, and advance their transformation to fully digital workflows.

German biotech company MODAG has announced the market launch of PD DETECT, the first CE-certified test kit for Parkinson’s disease.

Registration for the British Society For Microbial Technology’s 41st Annual Microbiology Conference is open now, with 'early-bird' prices available until 20 April. The event takes place on Thursday 21 May, at North London’s RAF Museum, Hendon.

Leica Biosystems has launched its breakthrough AI-Powered Karyotyping functionality on the CytoInsight GSL platform, marking a major technological advancement for cytogenetics laboratories seeking faster turnaround times, greater automation, and elevated consistency in chromosome analysis.

The Global Virus Network (GVN) marked the opening of its International Headquarters on 5 March at the University of South Florida (USF) Institute for Translational Virology and Innovation (ITVI), a GVN Center of Excellence.

An antibody test for the infectious disease Mpox was successfully developed during the new clade 1b outbreak in Rwanda, the first time that an assay of its kind has been validated within this setting.

The House of Lords Science and Technology Committee has launched an inquiry into innovation in the NHS, with a focus on personalised medicine and AI.

New analysis shows Clinical Practice Research Datalink has supported groundbreaking medical research across 29 countries with close to 3,800 published studies

Agilent Technologies has announced it has entered into a definitive agreement to acquire Biocare Medical, a global leader in clinical pathology, from an investor group led by Excellere Partners and GHO Capital Partners LLP, in an all-cash transaction valued at $950 million.

Eppendorf has announced the commercial launch of the SpinPro 6 R centrifuge, the first in the new range of SpinPro floor-standing and benchtop centrifuges.

Scientists at Duke-NUS Medical School have found that viruses circulating in live poultry markets can be detected more effectively by sampling the surrounding environment than by testing individual birds.

A new international research effort is underway to find the best ways to protect babies from respiratory syncytial virus (RSV), a common infection of the nose, throat and lungs that can cause serious breathing problems in young children.

AI pathology firm PathAI has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to PathAssist Derm, designed to analyse digital pathology whole slide images (WSIs) of skin lesions and aid pathologists in their review.

Leica Biosystems streamlines multiplex immunofluorescence (IF) for oncology and translational research with the launch of its BOND 4-Plex Fluorescent Detection Kit for research use only.

Rapid testing for bacterial infections is being rolled out in community pharmacies and GP surgeries across Wales.

Mount Sinai and King Saud University Medical City in Riyadh, Saudi Arabia, have announced a three-year collaboration aimed at better understanding why inflammatory bowel disease (IBD) runs in some Saudi families, and how that knowledge can lead to risk ascertainment, earlier diagnosis and more personalised treatment options.

Coronaviruses not only use the machinery of the human cells they infect; they modify it to achieve optimal conditions to produce viral proteins and thus spread more quickly.

AI-powered digital diagnostics company Techcyte has announced that its Fusion AP platform has achieved CE marking under the European In Vitro Diagnostic Regulation (IVDR).